Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Proton Nuclear Magnetic Resonance Metabonomics Approach for Biomarker Discovery in Nonalcoholic Fatty Liver Disease
Hao Li, Lan Wang, Xianzhong Yan, et al.
Journal of Proteome Research (2011) Vol. 10, Iss. 6, pp. 2797-2806
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar‐Gómez, Naga Chalasani
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 305-315
Closed Access | Times Cited: 522
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu, Yi Duan, Ling Yang, et al.
Gut (2018) Vol. 68, Iss. 2, pp. 359-370
Open Access | Times Cited: 304
NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations
Abdul‐Hamid Emwas, Reza M. Salek, Julian L. Griffin, et al.
Metabolomics (2013) Vol. 9, Iss. 5, pp. 1048-1072
Closed Access | Times Cited: 267
The metabolomic window into hepatobiliary disease
Diren Beyoğlu, Jeffrey R. Idle
Journal of Hepatology (2013) Vol. 59, Iss. 4, pp. 842-858
Open Access | Times Cited: 208
Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver Disease
Marc‐Emmanuel Dumas, James Kinross, Jeremy K. Nicholson
Gastroenterology (2013) Vol. 146, Iss. 1, pp. 46-62
Closed Access | Times Cited: 178
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease
April D. Lake, Petr Novák, Petia Shipkova, et al.
Toxicology and Applied Pharmacology (2013) Vol. 268, Iss. 2, pp. 132-140
Open Access | Times Cited: 171
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, et al.
Progress in Lipid Research (2015) Vol. 59, pp. 106-125
Open Access | Times Cited: 156
Biomarkers in Nonalcoholic Fatty Liver Disease
Manuela G. Neuman, Lawrence B. Cohen, Radu M. Nanau
Canadian Journal of Gastroenterology and Hepatology (2014) Vol. 28, Iss. 11, pp. 607-618
Open Access | Times Cited: 151
Phenotyping the effect of diet on non-alcoholic fatty liver disease
Nicole de Wit, Lydia A. Afman, Marco Mensink, et al.
Journal of Hepatology (2012) Vol. 57, Iss. 6, pp. 1370-1373
Open Access | Times Cited: 145
Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
You Zhou, Matej Orešič, Marja Leivonen, et al.
Clinical Gastroenterology and Hepatology (2016) Vol. 14, Iss. 10, pp. 1463-1472.e6
Open Access | Times Cited: 136
The acidic pathway of bile acid synthesis: Not just an alternative pathway
William M. Pandak, Genta Kakiyama
Liver Research (2019) Vol. 3, Iss. 2, pp. 88-98
Open Access | Times Cited: 123
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
Jorge Simón, Maitane Núñez-García, Pablo Fernández‐Tussy, et al.
Cell Metabolism (2020) Vol. 31, Iss. 3, pp. 605-622.e10
Open Access | Times Cited: 100
Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function
Alexander Lercher, Anannya Bhattacharya, Alexandra Popa, et al.
Immunity (2019) Vol. 51, Iss. 6, pp. 1074-1087.e9
Open Access | Times Cited: 95
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
Miriam Longo, Marica Meroni, Erika Paolini, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 3, pp. 759-788
Open Access | Times Cited: 76
Role of ammonia in NAFLD: An unusual suspect
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein Kerbert, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100780-100780
Open Access | Times Cited: 23
Clinical metabolomics paves the way towards future healthcare strategies
Sebastiano Collino, François‐Pierre Martin, Serge Rezzi
British Journal of Clinical Pharmacology (2012) Vol. 75, Iss. 3, pp. 619-629
Open Access | Times Cited: 100
Analysis of Bacterial Biofilms Using NMR-Based Metabolomics
Bo Zhang, Robert Powers
Future Medicinal Chemistry (2012) Vol. 4, Iss. 10, pp. 1273-1306
Open Access | Times Cited: 98
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 68
Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development
Yi-Syuan Lai, Wei-Cheng Chen, Tien-Chueh Kuo, et al.
Journal of Agricultural and Food Chemistry (2015) Vol. 63, Iss. 35, pp. 7873-7884
Closed Access | Times Cited: 67
Metabonomics Research Progress on Liver Diseases
Mengqian Yu, Ying Zhu, Qingwei Cong, et al.
Canadian Journal of Gastroenterology and Hepatology (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 62
Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
Shu Dong, Zong-Ying Zhan, Hongyan Cao, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 15, pp. 2771-2771
Open Access | Times Cited: 62
Protein and amino acids in nonalcoholic fatty liver disease
Domenico Tricò, Edoardo Biancalana, Anna Solini
Current Opinion in Clinical Nutrition & Metabolic Care (2020) Vol. 24, Iss. 1, pp. 96-101
Closed Access | Times Cited: 59
The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
Mikkel Werge, Adrian McCann, Elisabeth D. Galsgaard, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 1081-1081
Open Access | Times Cited: 45
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
Maria V. Bourganou, Maria Chondrogianni, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1589-1589
Open Access
Non-Alcoholic Steatohepatitis: New Insights from OMICS Studies
Cécile Martel, Davide Degli Esposti, A Bouchet, et al.
Current Pharmaceutical Biotechnology (2012) Vol. 13, Iss. 5, pp. 726-735
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top